PubMed Health⌕ Search

PubMed · 11640862

[Not Available].

Abstract

From the beginning, next to their essential function of preparing drugs pharmacies also served as educational institutions, in particular for the instruction of their own rising generation. Especially between 1750 and 1850 pharmacies in addition were engaged in scientific research. It were basically experimental-analytic chemistry and after 1800 mainly phytochemistry which inspired numerous apothecaries to do corresponding work in their laboratories. For many of those scientifically ambitious pharmacists, however, pharmacies were merely a starting point in their professional career. More or less rapidly, they turned to other places of activity which were organizationally, socially, and intellectually of higher standards (e.g. academies or universities). There, they were better able to realize their research interests frequently roused and shaped in the pharmacies. When around 1850 chemistry as an autonomous discipline definitely was established at the universities and competition became increasingly apparent through the rising chemical industry, the former meaning and function of pharmacies as places of scientific research disappeared more and more and was completely lost about 1900.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P Dilg. 2000. [Not Available].. https://doi.org/10.1002/bewi.20000230307

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Correlation of characteristics of gel extrusion module (GEM) tablet formulation and drug dissolution rate.

The purpose of the study was to characterize the swelling properties of controlled release tablet formulations with compositional and processing differences. A correlation was also established between the drug dissolution rate from the controlled release gel extrusion module (GEM) tablet and the swelling properties of the core tablet. The GEM tablet consisted of a core tablet of water swellable Carbopol polymer, a neutralizing agent, drug, and excipients. The tablet was subsequently coated with a rigid, water impermeable membrane. A number of holes were then drilled by laser through the impermeable membrane. Dynamic mechanical analysis (DMA), Perkin Elmer DMA7, was used to characterize the swelling properties. During the swelling measurements, the measuring probe and sample were completely submerged in the surrounding medium. The results showed that the formulation containing potassium phosphate dibasic as a neutralizing agent had the highest swelling rate. Correspondingly, this formulation had the highest drug dissolution rate over the same time period. The processing difference included wet granulation and dry roller compaction. The compositional differences included different neutralizing agents, binders or Carbopol polymers. The results showed a linear relationship (r(2)=0.954) between the swelling rates of the core tablets and the drug dissolution rates of GEM tablets. No correlation was found between the drug dissolution rates and either the maximum extent of tablet swelling or the time needed to reach the maximum extent of swelling. The results demonstrated that DMA could be used to support both formulation and process development to determine the effects of different compositions and manufacturing processes on drug dissolution rates for swelling controlled release devices.

Chemistry, Pharmaceutical↗

The effect of formulation variables on the stability of nebulized aviscumine.

The pulmonary drug delivery of proteins present an alternative to parenteral and oral administration. Nebulization of aqueous protein solutions is an ideal method for pulmonary application of therapeutic proteins considering the difficulties of their formulation as MDIs or DPIs. This research presents the effect of variable excipients on the stability of freeze-dried aviscumine after reconstitution and nebulization. Formulations containing different lyoprotectants have been lyophilized and reconstituted with isotonic salt solution. The loss of aviscumine activity in the nebulizer reservoir and after nebulization with a PariBoy air-jet nebulizer, a Multisonic ultrasonic nebulizer and a Systam ultrasonic nebulizer was determined by a binding assay. The effect of variable lyoprotectants such as 8% (w/v) Dextran T1, HES130, HES450, HP-beta-CD and 6% (w/v) HES450 plus 2% (w/v) mannitol on the stability of aviscumine to air-jet and ultrasonic nebulization has been evaluated. Only 50% of aviscumine activity was retained after 20 min nebulization, where 8% (w/v) HES450 was shown to be the best stabilizer. Stabilization of aviscumine by the addition of variable surfactants as 0.01 and 0.1% (w/v) Poloxamer 188, 0.03 and 0.1% (w/v) PEG 8000, 0.03 and 0.1% (w/v) Solutol HS15 and 0.03 and 0.1% (w/v) octanoyl-N-methyl-glucamide to the reconstitution solution has also been studied. By the addition of 0.03% (w/v) octanoyl-N-methyl-glucamide, 70% of the activity was retained after 20 min nebulization.

Chemistry, Pharmaceutical↗

Small particles of a heparin/chitosan complex prepared from a pharmaceutically acceptable microemulsion.

A water-in-oil microemulsion based on ingredients acceptable for oral administration of substances to human was investigated. The microemulsion was studied with and without biologically active ingredients by dynamic light scattering, turbidity, diffusion-NMR, and conductivity. Also, a technology based on mixing of appropriate microemulsions was investigated as a means to produce particles of nanometer size of a heparin/chitosan complex. It was found that the microemulsion existed up to about 15% (w/w) of water with or without active ingredients. Formation of nanosized heparin/chitosan particles inside the water droplets was confirmed. It was concluded that the investigated microemulsion could be an interesting system for the oral administration of a heparin/chitosan complex.

Chemistry, Pharmaceutical↗